Avoro Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
14
- Investments
-
62
- Portfolio
-
14
- Exits
-
47
Avoro Capital General Information
Company Description
Founded in 2009, Avoro Capital is a venture capital firm based in New York, New York. The firm provides investment advice and management to privately placed investment funds. The firm also provides investment advisory services to a separately managed account. The firm's investment objective is to achieve superior investment returns by making, primarily, long-term, early-stage investments in the equity and equity-related securities of healthcare companies, chiefly in the biotechnology subsector. The firm invests primarily in privately held companies.
Business Details
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 110 Greene Street
- Suite 800
- New York, NY 10012
- United States
Avoro Capital Investments (62)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Aadi Bioscience | 04-Mar-2025 | PIPE | Drug Discovery | Generating Revenue/Not Profitable | ||
| Ottimo Pharma | 12-Dec-2024 | Drug Discovery | Startup | |||
| ViceBio | 23-Sep-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Scorpion Therapeutics | 16-Jul-2024 | Drug Discovery | Generating Revenue | |||
| Krystal Biotech | 22-May-2023 | Biotechnology | Profitable | |||
| Tourmaline Bio | 02-May-2023 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Hemab | 15-Feb-2023 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Aadi Bioscience | 26-Sep-2022 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Kymera Therapeutics | 22-Aug-2022 | PIPE | Biotechnology | Generating Revenue/Not Profitable | ||
| Vanqua Bio | 14-Sep-2021 | Early Stage VC | Drug Discovery | Generating Revenue |
Avoro Capital Exits (47)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Monte Rosa Therapeutics | 16-May-2024 | Public Investment 2nd Offering | |
| Kymera Therapeutics | 05-Jan-2024 | ||
| Rocket Pharmaceuticals | 13-Sep-2023 | ||
| Madrigal Pharmaceuticals | 23-Dec-2022 | ||
| Aerie Pharmaceuticals | 21-Nov-2022 | ||
| Amylyx | 07-Jan-2022 | ||
| IO Biotech | 05-Nov-2021 | ||
| DICE Therapeutics | 15-Sep-2021 | ||
| Tango Therapeutics | 11-Aug-2021 | Reverse Merger | |
| Vividion Therapeutics | 01-Aug-2021 | Merger/Acquisition |
Avoro Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Avoro Capital Co-Investors (104)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Logos Capital | 6 |
|
|
||
| RA Capital Management |
|
|
|||
| OrbiMed |
|
|
|||
| Wellington Management |
|
|
|||
| venBio |
|
|
Avoro Capital FAQs
-
What is Avoro Capital?
Founded in 2009, Avoro Capital is a venture capital firm based in New York, New York.
-
When was Avoro Capital founded?
Avoro Capital was founded in 2009.
-
Where is Avoro Capital headquartered?
Avoro Capital is headquartered in New York, NY.
-
What is Avoro Capital's total asset value?
Avoro Capital has around in total assets under management.
-
How many investments has Avoro Capital made?
Avoro Capital has made 62 investments.
-
What has Avoro Capital invested in?
Avoro Capital has made numerous investments in companies like Aadi Bioscience, Ottimo Pharma, and ViceBio within the Drug Discovery industry.
-
What has Avoro Capital invested in recently?
Avoro Capital's latest investment was on 04-Mar-2025 in Aadi Bioscience, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
